Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2025)

Inspire Medical Systems (INSP) has disclosed Long-Term Investments for 7 consecutive years, with $96.3 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 35.69% to $96.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.3 million through Dec 2025, up 35.69% year-over-year, with the annual reading at $96.3 million for FY2025, 35.69% up from the prior year.
  • Long-Term Investments hit $96.3 million in Q4 2025 for Inspire Medical Systems, up from $88.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $113.4 million in Q3 2024 to a low of $204000.0 in Q1 2021.
  • Historically, Long-Term Investments has averaged $42.0 million across 5 years, with a median of $26.3 million in 2024.
  • Biggest five-year swings in Long-Term Investments: crashed 96.68% in 2021 and later skyrocketed 4701.96% in 2022.
  • Year by year, Long-Term Investments stood at $9.9 million in 2021, then decreased by 1.43% to $9.8 million in 2022, then decreased by 6.67% to $9.1 million in 2023, then skyrocketed by 676.5% to $71.0 million in 2024, then skyrocketed by 35.69% to $96.3 million in 2025.
  • Business Quant data shows Long-Term Investments for INSP at $96.3 million in Q4 2025, $88.4 million in Q3 2025, and $109.8 million in Q2 2025.